Case Study: Identification and Characterization of Unknown Impurities in an ANDA Submission
Introduction Impurity Identification for ANDA Submission becomes very important when unknown peaks appear during stability or release testing. If these […]
What is Required for an ANDA Submission in Generic Drug Development?
Introduction: Understanding the Requirements for ANDA Submission Generic Drugs is essential for any pharmaceutical company planning to enter the U.S.
What is Required for an ANDA Submission in Generic Drug Development? Read More »
Method Validation Requirements for ANDA: ICH Q2(R2) vs FDA Expectations
Introduction ANDA Method Validation Requirements require a high level of scientific and regulatory understanding. Although ICH Q2(R2) provides a harmonized
Method Validation Requirements for ANDA: ICH Q2(R2) vs FDA Expectations Read More »
Outsourcing Analytical Testing for ANDA Submissions: What to Look for in a CRO
Introduction: The process of Outsourcing Analytical Testing for ANDA Submissions requires choosing a Contract Research Organization (CRO) with proven experience
Outsourcing Analytical Testing for ANDA Submissions: What to Look for in a CRO Read More »
In-House vs CRO/CDMO for Generic Drug Development for ANDA
Introduction: When evaluating CRO vs In-house ANDA Development, it’s essential to understand that both approaches aim to successfully develop generic
In-House vs CRO/CDMO for Generic Drug Development for ANDA Read More »
Analytical Requirements for Generic Drug Development in ANDA Submissions
Introduction: The analytical requirements ANDA generic drugs must fulfill are the foundation of successful generic drug approval. In an ANDA
Analytical Requirements for Generic Drug Development in ANDA Submissions Read More »
Step-by-Step Process of Generic Drug Development for ANDA Submission
Introduction: The Generic Drug Development Process ANDA is a scientifically driven pathway that enables pharmaceutical companies to develop affordable and
Step-by-Step Process of Generic Drug Development for ANDA Submission Read More »
CRO/CDMO Services for Generic Drug Development for ANDA Submission
Introduction: In today’s competitive pharmaceutical landscape, partnering with a Generic Drug Development CRO for ANDA is essential for companies aiming
CRO/CDMO Services for Generic Drug Development for ANDA Submission Read More »
Benefits of Working With a Specialized Peptide CDMO for Generic and Innovative Drugs
Introduction: Specialized Peptide CDMO Services play a crucial role in the modern pharmaceutical landscape, particularly for companies developing both generic
Benefits of Working With a Specialized Peptide CDMO for Generic and Innovative Drugs Read More »
Key Analytical Challenges in GLP-1 Peptide Drugs and How CDMOs Solve Them
Introduction: GLP-1 Peptide Analytical Characterization plays a crucial role in ensuring the safety, efficacy, and regulatory compliance of peptide-based therapeutics.
Key Analytical Challenges in GLP-1 Peptide Drugs and How CDMOs Solve Them Read More »